7-F-7

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name7-F-7
Drug Alias Namehumanized anti-SARS-CoV-2 spike protein antibody (Leadgene Biomedical/Abnova (Taiwan))humanized neutralization antibody (Leadgene Biomedical/Abnova (Taiwan))humanized neutralization antibody (Abnova (Taiwan)/Leadgene Biomedical)humanized neutralization antibody (Abnova (Taiwan)/Leadgene Biomedical)humanized spike protein-neutralizing antibody (Leadgene Biomedical/Abnova (Taiwan)) +[6] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbnova (Taiwan) Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbnova (Taiwan) CorpLeadgene Biomedical Inc
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A